Stocks and Investing Stocks and Investing
Wed, May 17, 2023

Edward Nash Maintained (AKRO) at Strong Buy with Increased Target to $59 on, May 17th, 2023


Published on 2024-10-28 03:50:07 - WOPRAI, Edward Nash
  Print publication without navigation


Edward Nash of Canaccord Genuity, Maintained "Akero Therapeutics, Inc." (AKRO) at Strong Buy with Increased Target from $58 to $59 on, May 17th, 2023.

Edward has made no other calls on AKRO in the last 4 months.



There are 2 other peers that have a rating on AKRO. Out of the 2 peers that are also analyzing AKRO, 0 agree with Edward's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Edward


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $62 on, Tuesday, May 16th, 2023
  • Michael Ulz of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $65 on, Friday, January 27th, 2023

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com